Clinical confirmation of the american academy of neurology algorithm for HIV-1-associated cognitive/motor disorder

Neurology

Volumn 47, Issue 5, 1996, Pages 1247-1253

  Marder, K ^a  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FUNCTIONAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MOTOR DYSFUNCTION; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; VERBAL MEMORY;

EID: 0029961521     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.5.1247     Document Type: Article

References (33)

1. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology 1993;43: 2245-2252.
2. Janssen RS, Cornblath DR, Epstein LG, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection: report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:778-785.
3. Fahn S, Marsden C, Calne D. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information, 1987:153.
4. Butters N, Grant I, Haxby J, et al. Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workgroup on Neuropsychological Assessment Approaches. J Clin Exp Neuropsych 1990;12:963-978.
5. Concha M, Selnes OA, McArthur J, et al. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Intl J Addictions 1995;30:823-841.
6. Selnes OA, Jacobson L, Machado AM, et al. Normative data for a brief neuropsychological screening battery. Percept Mot Skills 1991;73:539-550.
7. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 1941;28:286-340.
8. Wechsler D. Wechsler Adult Intelligence Scale - Revised. New York, NY: The Psychological Corporation, 1981.
9. Klove H. Clinical neuropsychology. Med Clin North Am 1963; 46:1647-1658.
10. Benton AL. The Visual Retention Test. New York, NY: The Psychological Corporation, 1955.
11. Flowers KA, Robertson C. The effects of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry 1985;48:517-529.
12. Miller EN, Satz P, Visscher B. Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology 1991;41:1608-1616.
13. Nelson HE. The National Adult Reading Test (NART): test manual. London: The National Hospital for Nervous Diseases, 1982.
14. Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence levels using the National Adult Reading Test. Cortex 1978;14:234-244.
15. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
16. Katz S, Ford A, Moskowitz R, et al. Studies of illness in the aged: the index of ADL. JAMA 1963;183:914-919.
17. Stewart AL, Ware JE. Measuring function and well-being: the Medical Outcomes Study approach. Durham, NC: Duke University Press, 1993.
18. Karnofsky DA, Abelman WH, Carver LF, et al. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-656.
19. Radloff LL. The CES-D: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1: 385-401.
20. Stern Y, Liu X, Marder K, et al. Neuropsychological changes in a prospectively followed cohort of gay and bisexual men with and without HIV infection. Neurology 1995;45:467-472.
21. Stern Y, Liu X, Marder K, et al. Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV. Neuropsychiat Neuropsychol Beh Neurol 1996;9:83-90.
22. Royal W, Updike M, Seines OA, et al. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1992;42:1924-1930.
23. Marder K, Liu X, Stern Y, et al. Neurologic signs and symptoms in a cohort of homosexual men followed for 4.5 years. Neurology 1995;45:261-267.
24. Marder K, Liu X, Stern Y, et al. Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users. Arch Neurol 1995;52:1174-1182.
25. Aylward EH, Henderer JD, McArthur JC, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993;43:2099-2104.
26. Brew BJ, Rosenblum M, Cronin K, Price R. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-571.
27. Navia B, Cho ES, Petito CK, Price RW. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986;19:525-535.
28. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis: pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (Berlin) 1990;80: 393-400.
29. Albert SM, Marder K, Dooneief G, et al. Neuropsychologic impairment in early HIV infection: a risk factor for work disability. Arch Neurol 1995;52:525-530.
30. Albert SM, Todak G, Elkin E, Marder K, Dooneief G, Stern Y. Time allocation and disability in HIV infection: a correlational study. J Occup Sci 1995;1:21-30.
31. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992;1:359-366.
32. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection. Med Care 1991;29:786-798.
33. O'Dell MW, Lubeck DP, O'Driscoll P, Matsuno S. Validity of the Karnofsky performance status in an HIV-infected sample. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:350-357.